Aging Biology and The Power of Human Data, Kristen Fortney, Co-Founder and CEO, BioAge
Synopsis: In a recent episode of Biotech2050, hosted by Alok Tayi, Kristen Fortney, CEO of BioAge, provides valuable insights into the evolving landscape of aging biology and the innovative approach ...
21 Feb 202426min
The Intersection Of Tech and Biotech, Chris Gibson, Co-Founder & CEO, Recursion
Synopsis: In this episode of the Biotech2050 podcast, Chris Gibson, the co-founder and CEO of Recursion, shares insights on the intersection of technology and biotech, emphasizing the importance of a...
14 Feb 202439min
Psychedelics, Longevity, and Wellbeing, Christian Angermayer, Founder, Apeiron Investment Group
Synopsis: Christian Angermayer, a prominent investor and entrepreneur in the biotech industry, shares valuable insights in the Biotech2050 podcast, shedding light on the challenges and opportunities ...
7 Feb 202446min
Navigating Platform vs Product Tension, David Kirn, Co-Founder & CEO, 4DMT
Synopsis: In this episode of the Biotech2050 podcast, David Kirn, CEO of 4D Molecular Therapeutics, shares invaluable insights for aspiring entrepreneurs in the biotech industry. Kirn discusses the d...
31 Jan 202433min
Adapting Through Disruption in Biotech, David Esposito, President & CEO, ONL Therapeutics
Synopsis: In this episode of the Biotech2050 podcast, David Esposito, CEO of ONL Therapeutics, provides valuable insights into the challenges and opportunities in the field of ophthalmology. Esposito'...
10 Jan 202425min
Overcoming Capital Challenges in Biotech, Jak Knowles, President & CEO, Affini-T Therapeutics
Synopsis: In this episode of the Biotech2050 podcast, Jak Knowles, co-founder of Affini-T Therapeutics, shares valuable insights into the challenges faced by bootstrapped biotech companies and the si...
13 Des 202326min
A novel approach to advancing breast cancer therapy, Sean Bohen, President & CEO, Olema Oncology
Synopsis: Sean Bohen, M.D., Ph.D., is the President and CEO of Olema Oncology, a biopharmaceutical company developing innovative targeted therapies for women’s cancers. We’re excited to welcome Sean ...
6 Des 202320min
The promise of precision oncology, Troy Wilson, President & CEO, Kura Oncology
Synopsis: Troy Wilson, Ph.D., J.D., is the President and CEO of Kura Oncology, a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment o...
29 Nov 202333min
